{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:00:37Z","timestamp":1793048437396,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603384"],"award-info":[{"award-number":["81603384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82122074"],"award-info":[{"award-number":["82122074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["20ZR1473300"],"award-info":[{"award-number":["20ZR1473300"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["23ZR1463200"],"award-info":[{"award-number":["23ZR1463200"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["17QA1403600"],"award-info":[{"award-number":["17QA1403600"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Talents Development Foundation","award":["2020099"],"award-info":[{"award-number":["2020099"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00204-024-03762-x","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T02:01:26Z","timestamp":1714788086000},"page":"2557-2576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Functional metabolomics characterizes the contribution of farnesoid X receptor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome"],"prefix":"10.1007","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6528-4652","authenticated-orcid":false,"given":"Aizhen","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunjiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzheng","family":"Zhuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,4]]},"reference":[{"issue":"9","key":"3762_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/gm489","volume":"5","author":"J Aubrecht","year":"2013","unstructured":"Aubrecht J, Schomaker SJ, Amacher DE (2013) Emerging hepatotoxicity biomarkers and their potential to improve understanding and management of drug-induced liver injury. Genome Med 5(9):85","journal-title":"Genome Med"},{"issue":"1","key":"3762_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11306-018-1460-7","volume":"15","author":"RD Beger","year":"2019","unstructured":"Beger RD, Dunn WB, Bandukwala A, Bethan B, Broadhurst D, Clish CB, Dasari S, Derr L, Evans A, Fischer S, Flynn T, Hartung T, Herrington D, Higashi R, Hsu PC, Jones C, Kachman M, Karuso H, Kruppa G, Lippa K, Maruvada P, Mosley J, Ntai I, O\u2019Donovan C, Playdon M, Raftery D, Shaughnessy D, Souza A, Spaeder T, Spalholz B, Tayyari F, Ubhi B, Verma M, Walk T, Wilson I, Witkin K, Bearden DW, Zanetti KA (2019) Towards quality assurance and quality control in untargeted metabolomics studies. Metabolomics 15(1):4","journal-title":"Metabolomics"},{"issue":"5","key":"3762_CR3","doi-asserted-by":"publisher","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","volume":"116","author":"NP Chalasani","year":"2021","unstructured":"Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR (2021) Practice parameters committee of the american college of gastroenterology. ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 116(5):878\u2013898","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"3762_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","volume":"58","author":"WH Chen","year":"2020","unstructured":"Chen WH, Wei YR, Xiong AZ, Li YM, Guan H, Wang Q, Miao Q, Bian Z, Xiao X, Lian M, Zhang J, Li B, Cao Q, Fan Z, Zhang W, Qiu D, Fang J, Gershwin ME, Yang L, Tang RQ, Ma X (2020a) Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in Primary Biliary Cholangitis. Clin Rev Allergy Immunol 58(1):25\u201338","journal-title":"Clin Rev Allergy Immunol"},{"key":"3762_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.toxlet.2020.01.021","volume":"323","author":"Y Chen","year":"2020","unstructured":"Chen Y, Xiong F, Wang WQ, Jiang KY, Ye XL, Deng G, Wang CH, Yang L, Xiong AZ, Wang ZT (2020b) The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica. Toxicol Lett 323:41\u201347","journal-title":"Toxicol Lett"},{"issue":"3","key":"3762_CR6","doi-asserted-by":"publisher","first-page":"G349","DOI":"10.1152\/ajpgi.00417.2002","volume":"284","author":"JY Chiang","year":"2003","unstructured":"Chiang JY (2003) Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. Am J Physiol Gastrointest Liver Physiol 284(3):G349\u2013G356","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3762_CR7","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","volume":"46","author":"G Danan","year":"1993","unstructured":"Danan G, B\u00e9nichou C (1993) Causality assessment of adverse reactions to drugs\u2013I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol 46:1323\u20131330","journal-title":"J Clin Epidemiol"},{"key":"3762_CR8","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/hep.510290615","volume":"29","author":"LD DeLeve","year":"1999","unstructured":"DeLeve LD, McCuskey RS, Wang X, Hu L, McCuskey MK, Epstein RB, Kanel GC (1999) Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 29:1779\u20131791","journal-title":"Hepatology"},{"key":"3762_CR9","doi-asserted-by":"publisher","first-page":"G1045","DOI":"10.1152\/ajpgi.00526.2002","volume":"284","author":"LD DeLeve","year":"2003","unstructured":"DeLeve LD, Ito Y, Bethea NW, McCuskey MK, Wang X, McCuskey RS (2003) Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome. Am J Physiol Gastrointest Liver Physiol 284:G1045\u2013G1052","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3762_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2019388118","volume":"118","author":"LL Ding","year":"2021","unstructured":"Ding LL, Zhang EY, Yang Q, Jin L, Sousa KM, Dong B, Wang Y, Tu J, Ma X, Tian J, Zhang H, Fang Z, Guan A, Zhang Y, Wang ZT, Moore DD, Yang L, Huang WD (2021) Vertical sleeve gastrectomy confers metabolic improvements by reducing intestinal bile acids and lipid absorption in mice. Proc Natl Acad Sci U S A 118:e2019388118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3762_CR11","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.2147\/DDDT.S87858","volume":"9","author":"H Gao","year":"2015","unstructured":"Gao H, Ruan JQ, Chen J, Li N, Ke CQ, Ye Y, Lin G, Wang JY (2015) Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome. Drug Des Devel Ther 9:4861\u20134868","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"3762_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jhep.2022.01.020","volume":"77","author":"A Ghallab","year":"2022","unstructured":"Ghallab A, Hassan R, Hofmann U, Friebel A, Hobloss Z, Brackhagen L, Begher-Tibbe B, Myllys M, Reinders J, Overbeck N, Sezgin S, Z\u00fchlke S, Seddek AL, Murad W, Brecklinghaus T, Kappenberg F, Rahnenf\u00fchrer J, Gonz\u00e1lez D, Goldring C, Copple IM, Marchan R, Longerich T, Vucur M, Luedde T, Urban S, Canbay A, Schreiter T, Trauner M, Akakpo JY, Olyaee M, Curry SC, Sowa JP, Jaeschke H, Hoehme S, Hengstler JG (2022) Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity. J Hepatol 77(1):71\u201383","journal-title":"J Hepatol"},{"key":"3762_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","volume":"6","author":"B Goodwin","year":"2000","unstructured":"Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewei SA (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517\u2013526","journal-title":"Mol Cell"},{"issue":"12","key":"3762_CR14","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1016\/j.apsb.2021.07.013","volume":"11","author":"Y He","year":"2021","unstructured":"He Y, Ma J, Fan X, Ding L, Ding X, Zhang QY, Lin G (2021) The key role of gut-liver axis in pyrrolizidine alkaloid-induced hepatotoxicity and enterotoxicity. Acta Pharm Sin B 11(12):3820\u20133835","journal-title":"Acta Pharm Sin B"},{"key":"3762_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00204-019-02582-8","volume":"94","author":"S Hessel-Pras","year":"2020","unstructured":"Hessel-Pras S, Braeuning A, Guenther G, Adawy A, Enge AM, Ebmeyer J, Henderson CJ, Hengstler JG, Lampen A, Reif R (2020) The pyrrolizidine alkaloid senecionine induces CYP-dependent destruction of sinusoidal endothelial cells and cholestasis in mice. Arch Toxicol 94:219\u2013229","journal-title":"Arch Toxicol"},{"key":"3762_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1056\/NEJMra1816149","volume":"381","author":"JH Hoofnagle","year":"2019","unstructured":"Hoofnagle JH, Bj\u00f6rnsson ES (2019) Drug-induced liver injury\u2014types and phenotypes. N Engl J Med 381:264\u2013273","journal-title":"N Engl J Med"},{"key":"3762_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101117","volume":"22","author":"ZL Huang","year":"2019","unstructured":"Huang ZL, Jing X, Sheng Y, Zhang J, Hao Z, Wang ZT, Ji LL (2019) (-)-Epicatechin attenuates hepatic sinusoidal obstruction syndrome by inhibiting liver oxidative and inflammatory injury. Redox Biol 22:101117","journal-title":"Redox Biol"},{"key":"3762_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","volume":"2","author":"T Inagaki","year":"2005","unstructured":"Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, Gerard RD, Repa JJ, Mangelsdorf DJ, Kliewer SA (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2:217\u2013225","journal-title":"Cell Metab"},{"key":"3762_CR19","volume-title":"Environmental health criteria 80: pyrrolizidine alkaloids","author":"IPCS; International Programme on Chemical Safety","year":"1988","unstructured":"IPCS; International Programme on Chemical Safety (1988) Environmental health criteria 80: pyrrolizidine alkaloids. World Health Organization, Geneva"},{"key":"3762_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, Vogelsang GB, Sensenbrenner LL, Santos GW, Saral R (1987) Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 44:778\u2013783","journal-title":"Transplantation"},{"key":"3762_CR21","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1210\/me.2010-0117","volume":"24","author":"FY Lee","year":"2010","unstructured":"Lee FY, de Aguiar Vallim TQ, Chong HK, Zhang Y, Liu Y, Jones SA, Osborne TF, Edwards PA (2010) Activation of the farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity. Mol Endocrinol 24:1626\u20131636","journal-title":"Mol Endocrinol"},{"key":"3762_CR22","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1172\/JCI0216309","volume":"110","author":"J Li-Hawkins","year":"2002","unstructured":"Li-Hawkins J, G\u00e5fvels M, Olin M, Lund EG, Andersson U, Schuster G, Bj\u00f6rkhem I, Russell DW, Eggertsen G (2002) Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. J Clin Invest 110:1191\u20131200","journal-title":"J Clin Invest"},{"issue":"4","key":"3762_CR23","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jhep.2010.07.031","volume":"54","author":"G Lin","year":"2011","unstructured":"Lin G, Wang JY, Li N, Li M, Gao H, Ji Y, Zhang F, Wang H, Zhou Y, Ye Y, Xu HX, Zheng J (2011) Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatology 54(4):666\u2013673","journal-title":"J Hepatology"},{"key":"3762_CR24","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","volume":"284","author":"M Makishima","year":"1999","unstructured":"Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B (1999) Identification of a nuclear receptor for bile acids. Science 284:1362\u20131365","journal-title":"Science"},{"key":"3762_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED (1984) Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 4:116\u2013122","journal-title":"Hepatology"},{"key":"3762_CR26","first-page":"572","volume":"49","author":"VE Mendel","year":"1988","unstructured":"Mendel VE, Witt MR, Gitchell BS, Gribble DN, Rogers QR, Segall HJ, Knight HD (1988) Pyrrolizidine alkaloid-induced liver disease in horses: an early diagnosis. Am J Vet Res 49:572\u2013578","journal-title":"Am J Vet Res"},{"key":"3762_CR27","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/bmt.2016.130","volume":"51","author":"M Mohty","year":"2016","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E (2016) Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant 51:906\u2013912","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"3762_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0022-2275(20)41693-1","volume":"18","author":"NB Myant","year":"1977","unstructured":"Myant NB, Mitropoulos KA (1977) Cholesterol 7 alpha-hydroxylase. J Lipid Res 18(2):135\u2013153","journal-title":"J Lipid Res"},{"key":"3762_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, Drenth JP, Pockros PJ, Regula J, Beuers U, Trauner M, Jones DE, Floreani A, Hohenester S, Luketic V, Shiffman M, van Erpecum KJ, Vargas V, Vincent C, Hirschfield GM, Shah H, Hansen B, Lindor KD, Marschall HU, Kowdley KV, Hooshmand-Rad R, Marmon T, Sheeron S, Pencek R, MacConell L, Pruzanski M, Shapiro D, POISE Study Group (2016) A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med 375:631\u2013643","journal-title":"N Engl J Med"},{"issue":"11","key":"3762_CR30","doi-asserted-by":"publisher","first-page":"870","DOI":"10.2174\/1389200222666210427124332","volume":"22","author":"X Pang","year":"2021","unstructured":"Pang X, Tang C, Cao P, Zhou L, Chen X (2021) Metabolic activation of retrorsine may disrupt bile acid homeostasis in mice through the Nrf2 pathway. Curr Drug Metab 22(11):870\u2013881","journal-title":"Curr Drug Metab"},{"key":"3762_CR31","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","volume":"284","author":"DJ Parks","year":"1999","unstructured":"Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM (1999) Bile acids: Natural ligands for an orphan nuclear receptor. Science 284:1365\u20131368","journal-title":"Science"},{"key":"3762_CR32","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1021\/jm025529g","volume":"45","author":"R Pellicciari","year":"2002","unstructured":"Pellicciari R, Fiorucci S, Camaioni E, Clerici C, Costantino G, Maloney PR, Morelli A, Parks DJ, Willson TM (2002) 6\u03b1-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. J Med Chem 45:3569\u20133572","journal-title":"J Med Chem"},{"key":"3762_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","volume":"72","author":"DW Russell","year":"2003","unstructured":"Russell DW (2003) The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72:137\u2013174","journal-title":"Annu Rev Biochem"},{"issue":"5","key":"3762_CR34","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1021\/acs.jproteome.0c00852","volume":"20","author":"C Sang","year":"2021","unstructured":"Sang C, Wang X, Zhou K, Sun T, Bian H, Gao X, Wang Y, Zhang H, Jia W, Liu P, Xie G, Chen T (2021) Bile acid profiles are distinct among patients with different etiologies of chronic liver disease. J Proteome Res 20(5):2340\u20132351","journal-title":"J Proteome Res"},{"issue":"3","key":"3762_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.clinre.2015.12.017","volume":"40","author":"HS Schadt","year":"2016","unstructured":"Schadt HS, Wolf A, Pognan F, Chibout SD, Merz M, Kullak-Ublick GA (2016) Bile acids in drug induced liver injury: Key players and surrogate markers. Clin Res Hepatol Gastroenterol 40(3):257\u2013266","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"4","key":"3762_CR36","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jhep.2016.12.005","volume":"66","author":"P Schwabl","year":"2017","unstructured":"Schwabl P, Hambruch E, Seeland BA, Hayden H, Wagner M, Garnys L, Strobel B, Schubert TL, Riedl F, Mitteregger D, Burnet M, Starlinger P, Oberhuber G, Deuschle U, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Reiberger T, Kremoser C, Trauner M (2017) The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodeling and sinusoidal dysfunction. J Hepatol 66(4):724\u2013733","journal-title":"J Hepatol"},{"key":"3762_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21037\/atm-20-731","volume":"9","author":"H Shang","year":"2021","unstructured":"Shang H, Bai T, Zhu S, Yang X, Liu C, Xu D, Zhuge Y, Song Y, Hou X (2021) Prognostic factors for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: a multicenter study in China. Ann Transl Med 9:11","journal-title":"Ann Transl Med"},{"key":"3762_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hep.22627","volume":"49","author":"KH Song","year":"2009","unstructured":"Song KH, Li T, Owsley E, Strom S, Chiang JY (2009) Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7 alpha-hydroxylase gene expression. Hepatology 49:297\u2013305","journal-title":"Hepatology"},{"key":"3762_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1939-165X.1992.tb00583.x","volume":"21","author":"RJ Sutherland","year":"1992","unstructured":"Sutherland RJ, Deol HS, Hood PJ (1992) Changes in plasma bile acids, plasma amino acids, and hepatic enzyme pools as indices of functional impairment in liver-damaged sheep. Vet Clin Pathol 21:51\u201356","journal-title":"Vet Clin Pathol"},{"issue":"5","key":"3762_CR40","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.cgh.2020.06.067","volume":"19","author":"Q Tian","year":"2021","unstructured":"Tian Q, Yang R, Wang Y, Liu J, Wee A, Saxena R, Wang L, Li M, Liu L, Shan S, Kong Y, Ma H, Ou X, You H, Zhao X, Jia J (2021) A high serum level of taurocholic acid is correlated with the severity and resolution of drug-induced liver injury. Clin Gastroenterol Hepatol 19(5):1009\u20131019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3762_CR41","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/hep.26939","volume":"59","author":"L Verbeke","year":"2014","unstructured":"Verbeke L, Farre R, Trebicka J, Komuta M, Roskams T, Klein S, Elst IV, Windmolders P, Vanuytsel T, Nevens F, Laleman W (2014) Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. Hepatology 59:2286\u20132298","journal-title":"Hepatology"},{"issue":"1","key":"3762_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/foods10010161","volume":"10","author":"J Waizenegger","year":"2021","unstructured":"Waizenegger J, Gl\u00fcck J, Henricsson M, Luckert C, Braeuning A, Hessel-Pras S (2021) Pyrrolizidine alkaloids disturb bile acid homeostasis in the human hepatoma cell line HepaRG. Foods 10(1):161","journal-title":"Foods"},{"key":"3762_CR43","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/cr.2008.289","volume":"18","author":"YD Wang","year":"2008","unstructured":"Wang YD, Chen WD, Moore DD, Huang WD (2008) FXR: a metabolic regulator and cell protector. Cell Res 18:1087\u20131095","journal-title":"Cell Res"},{"key":"3762_CR44","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12876-018-0879-7","volume":"18","author":"Y Wang","year":"2018","unstructured":"Wang Y, Qiao D, Li Y, Xu F (2018) Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: A retrospective study. BMC Gastroenterol 18:156","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"3762_CR45","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s00204-022-03281-7","volume":"96","author":"WQ Wang","year":"2022","unstructured":"Wang WQ, Chen Y, Yin Y, Wang XJ, Ye XL, Jiang KY, Zhang Y, Zhang JW, Zhang W, Zhuge YZ, Chen L, Peng C, Xiong AZ, Yang L, Wang ZT (2022a) A TMT-based shotgun proteomics uncovers overexpression of thrombospondin 1 as a contributor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Arch Toxicol 96(7):2003\u20132019","journal-title":"Arch Toxicol"},{"key":"3762_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154162","volume":"102","author":"Z Wang","year":"2022","unstructured":"Wang Z, Ma J, He Y, Miu KK, Yao S, Tang C, Ye Y, Lin G (2022b) Nrf2-mediated liver protection by 18\u03b2-glycyrrhetinic acid against pyrrolizidine alkaloid-induced toxicity through PI3K\/Akt\/GSK3\u03b2 pathway. Phytomedicine 102:154162","journal-title":"Phytomedicine"},{"issue":"9","key":"3762_CR47","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.jpha.2023.06.003","volume":"13","author":"J Wei","year":"2023","unstructured":"Wei J, Chen T, Liu YM, Sun S, Yuan Z, Zhang Y, Xiong AZ, Li LN, Wang ZT, Yang L (2023) Targeted bile acids metabolomics in cholesterol gallbladder polyps and gallstones: From analytical method development towards application to clinical samples. J Pharm Anal 13(9):1080\u20131087","journal-title":"J Pharm Anal"},{"key":"3762_CR48","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(01)00020-4","volume":"196","author":"FC Willmot","year":"1920","unstructured":"Willmot FC, Robertson GW (1920) Senecio disease, or cirrhosis of the liver due to Senecio poisoning. Lancet 196:848\u2013849","journal-title":"Lancet"},{"key":"3762_CR49","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/toxsci\/kfu195","volume":"142","author":"BL Woolbright","year":"2014","unstructured":"Woolbright BL, McGill MR, Staggs VS, Winefield RD, Gholami P, Olyaee M, Sharpe MR, Curry SC, Lee WM, Jaeschke H, Acute Liver Failure Study Group (2014) Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients. Toxicol Sci 142:436\u2013444","journal-title":"Toxicol Sci"},{"key":"3762_CR50","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1021\/tx400451q","volume":"27","author":"AZ Xiong","year":"2014","unstructured":"Xiong AZ, Yang F, Fang L, Yang L, He Y, Wan YJ, Xu Y, Qi M, Wang X, Yu K, Tsim KW, Wang ZT (2014) Metabolomic and genomic evidence for compromised bile acid homeostasis by senecionine, a hepatotoxic pyrrolizidine alkaloid. Chem Res Toxicol 27:775\u2013786","journal-title":"Chem Res Toxicol"},{"key":"3762_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.phymed.2018.06.015","volume":"54","author":"AZ Xiong","year":"2019","unstructured":"Xiong AZ, Shao YL, Fang L, Yang X, Zhang S, Zheng J, Ding W, Yang L, Wang ZT (2019) Comparative analysis of toxic components in different medicinal parts of Gynura japonica and its toxicity assessment on mice. Phytomedicine 54:77\u201388","journal-title":"Phytomedicine"},{"issue":"2","key":"3762_CR52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/hep.32270","volume":"76","author":"H Xiong","year":"2022","unstructured":"Xiong H, Zhang C, Han L, Xu T, Saeed K, Han J, Liu J, Klaassen CD, Gonzalez FJ, Lu Y, Zhang Y (2022) Suppressed farnesoid X receptor by iron overload in mice and humans potentiates iron-induced hepatotoxicity. Hepatology 76(2):387\u2013403","journal-title":"Hepatology"},{"key":"3762_CR53","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.taap.2013.01.018","volume":"268","author":"M Yamazaki","year":"2013","unstructured":"Yamazaki M, Miyake M, Sato H, Masutomi N, Tsutsui N, Adam KP, Alexander DC, Lawton KA, Milburn MV, Ryals JA, Wulff JE, Guo L (2013) Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats. Toxicol Appl Pharmacol 268:79\u201389","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"3762_CR54","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/toxsci\/kfab027","volume":"181","author":"T Yan","year":"2021","unstructured":"Yan T, Yan N, Wang H, Yagai T, Luo Y, Takahashi S, Zhao M, Krausz KW, Wang G, Hao H, Gonzalez FJ (2021) FXR-deoxycholic acid-TNF-\u03b1 axis modulates acetaminophen-induced hepatotoxicity. Toxicol Sci 181(2):273\u2013284","journal-title":"Toxicol Sci"},{"key":"3762_CR55","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","volume":"67","author":"F Yang","year":"2007","unstructured":"Yang F, Huang X, Yi T, Yen Y, Moore DD, Huang WD (2007) Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res 67:863\u2013867","journal-title":"Cancer Res"},{"key":"3762_CR57","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1021\/tx800225q","volume":"21","author":"L Yang","year":"2008","unstructured":"Yang L, Xiong AZ, He YQ, Wang ZY, Wang CH, Wang ZT, Li W, Yang L, Hu ZB (2008) Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: Quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry. Chem Res Toxicol 21:2280\u20132288","journal-title":"Chem Res Toxicol"},{"key":"3762_CR56","doi-asserted-by":"publisher","first-page":"33052","DOI":"10.1038\/srep33052","volume":"6","author":"F Yang","year":"2016","unstructured":"Yang F, Tang X, Ding L, Zhou Y, Yang Q, Gong J, Wang G, Wang Z, Yang L (2016) Curcumin protects ANIT-induced cholestasis through signaling pathway of FXR-regulated bile acid and inflammation. Sci Rep 6:33052","journal-title":"Sci Rep"},{"key":"3762_CR58","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.redox.2017.02.020","volume":"12","author":"X Yang","year":"2017","unstructured":"Yang X, Wang H, Ni HM, Xiong AZ, Wang ZT, Sesaki H, Ding WX, Yang L (2017) Inhibition of Drp1 protects against senecionine-induced mitochondria-mediated apoptosis in primary hepatocytes and in mice. Redox Biol 12:264\u2013273","journal-title":"Redox Biol"},{"key":"3762_CR59","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.031139","volume":"137","author":"L Zhang","year":"2018","unstructured":"Zhang L, Wei TT, Li Y, Li J, Fan Y, Huang FQ, Cai YY, Ma G, Liu JF, Chen QQ, Wang SL, Li H, Alolga RN, Liu B, Zhao DS, Shen JH, Wang XM, Zhu W, Li P, Qi LW (2018) Functional metabolomics characterizes a key role for N-acetylneuraminic acid in coronary artery diseases. Circulation 137:1374\u20131390","journal-title":"Circulation"},{"key":"3762_CR60","first-page":"345","volume":"9","author":"W Zhang","year":"2021","unstructured":"Zhang W, Liu L, Zhang M, Zhang F, Peng C, Zhang B, Chen J, Li L, He J, Xiao J, Feng Y, Wang X, Xiong A, Yang L, Zou X, Yu Y, Zhuge YZ (2021) Validation of the Nanjing Criteria for diagnosing pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome. J Clin Transl Hepatol 9:345\u2013352","journal-title":"J Clin Transl Hepatol"},{"issue":"8","key":"3762_CR61","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41401-020-00553-9","volume":"42","author":"L Zhu","year":"2021","unstructured":"Zhu L, Zhang CY, Li DP, Chen HB, Ma J, Gao H, Ye Y, Wang JY, Fu PP, Lin G (2021) Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China. Acta Pharmacol Sin 42(8):1212\u20131222","journal-title":"Acta Pharmacol Sin"},{"key":"3762_CR62","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1111\/liv.13684","volume":"38","author":"YZ Zhuge","year":"2018","unstructured":"Zhuge YZ, Wang Y, Zhang F, Zhu CK, Zhang W, Zhang M, He Q, Yang J, He J, Chen J, Zou XP (2018) Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease. Liver Int 38:1867\u20131874","journal-title":"Liver Int"},{"key":"3762_CR63","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/jgh.14612","volume":"34","author":"YZ Zhuge","year":"2019","unstructured":"Zhuge YZ, Liu Y, Xie W, Zou X, Xu J, Wang J (2019) Chinese society of gastroenterology committee of hepatobiliary disease. Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. J Gastroenterol Hepatol 34:634\u2013642","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03762-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-024-03762-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03762-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T04:02:26Z","timestamp":1721880146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-024-03762-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,4]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["3762"],"URL":"https:\/\/doi.org\/10.1007\/s00204-024-03762-x","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,4]]},"assertion":[{"value":"26 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no completing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approved by Shanghai University of Traditional Chinese Medicine and Drum Tower Hospital of Nanjing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have agreed to publish this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}